21st Century Adult Cancer Sourcebook: Chronic Myelogenous Leukemia (CML) - Clinical Data for Patients, Families, and Physicians

Nonfiction, Health & Well Being, Health, Ailments & Diseases, Cancer, Medical
Cover of the book 21st Century Adult Cancer Sourcebook: Chronic Myelogenous Leukemia (CML) - Clinical Data for Patients, Families, and Physicians by Progressive Management, Progressive Management
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Progressive Management ISBN: 9781465990242
Publisher: Progressive Management Publication: October 4, 2011
Imprint: Smashwords Edition Language: English
Author: Progressive Management
ISBN: 9781465990242
Publisher: Progressive Management
Publication: October 4, 2011
Imprint: Smashwords Edition
Language: English

Authoritative information and practical advice from the nation's cancer experts about chronic myelogenous leukemia (CML) includes official medical data on signs, symptoms, early detection, diagnostic testing, risk factors and prevention, treatment options, surgery, radiation, drugs, chemotherapy, staging, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to understand the diagnosis and treatment of CML.

Comprehensive data on clinical trials related to CML is included - - with information on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.

Chronic myelogenous leukemia is a disease in which the bone marrow makes too many white blood cells. Chronic myelogenous leukemia (also called CML or chronic granulocytic leukemia) is a slowly progressing blood and bone marrow disease that usually occurs during or after middle age, and rarely occurs in children. Normally, the bone marrow makes blood stem cells (immature cells) that develop into mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell. The lymphoid stem cell develops into a white blood cell. The myeloid stem cell develops into one of three types of mature blood cells: Red blood cells that carry oxygen and other materials to all tissues of the body. Platelets that help prevent bleeding by causing blood clots to form. Granulocytes (white blood cells) that fight infection and disease. In CML, too many blood stem cells develop into a type of white blood cell called granulocytes. These granulocytes are abnormal and do not become healthy white blood cells. They may also be called leukemic cells. The leukemic cells can build up in the blood and bone marrow so there is less room for healthy white blood cells, red blood cells, and platelets. When this happens, infection, anemia, or easy bleeding may occur. Possible signs of chronic myelogenous leukemia include tiredness, night sweats, and fever.

At the time of diagnosis of patients with CML, splenomegaly is the most common finding on physical examination. The spleen may be enormous, filling most of the abdomen and presenting a significant clinical problem, or the spleen may be only minimally enlarged. In about 10% of patients, the spleen is neither palpable nor enlarged on splenic scan.

Extensive supplements, with chapters gathered from our Cancer Toolkit series and other reports, cover a broad range of cancer topics useful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical information, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:

Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background Information and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute's Center for Cancer Research at the National Institutes of Health Clinical Center
Taking Time: Support for People with Cancer
Facing Forward - Life After Cancer Treatment
Chemotherapy and You

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Authoritative information and practical advice from the nation's cancer experts about chronic myelogenous leukemia (CML) includes official medical data on signs, symptoms, early detection, diagnostic testing, risk factors and prevention, treatment options, surgery, radiation, drugs, chemotherapy, staging, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to understand the diagnosis and treatment of CML.

Comprehensive data on clinical trials related to CML is included - - with information on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.

Chronic myelogenous leukemia is a disease in which the bone marrow makes too many white blood cells. Chronic myelogenous leukemia (also called CML or chronic granulocytic leukemia) is a slowly progressing blood and bone marrow disease that usually occurs during or after middle age, and rarely occurs in children. Normally, the bone marrow makes blood stem cells (immature cells) that develop into mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell. The lymphoid stem cell develops into a white blood cell. The myeloid stem cell develops into one of three types of mature blood cells: Red blood cells that carry oxygen and other materials to all tissues of the body. Platelets that help prevent bleeding by causing blood clots to form. Granulocytes (white blood cells) that fight infection and disease. In CML, too many blood stem cells develop into a type of white blood cell called granulocytes. These granulocytes are abnormal and do not become healthy white blood cells. They may also be called leukemic cells. The leukemic cells can build up in the blood and bone marrow so there is less room for healthy white blood cells, red blood cells, and platelets. When this happens, infection, anemia, or easy bleeding may occur. Possible signs of chronic myelogenous leukemia include tiredness, night sweats, and fever.

At the time of diagnosis of patients with CML, splenomegaly is the most common finding on physical examination. The spleen may be enormous, filling most of the abdomen and presenting a significant clinical problem, or the spleen may be only minimally enlarged. In about 10% of patients, the spleen is neither palpable nor enlarged on splenic scan.

Extensive supplements, with chapters gathered from our Cancer Toolkit series and other reports, cover a broad range of cancer topics useful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical information, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:

Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background Information and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute's Center for Cancer Research at the National Institutes of Health Clinical Center
Taking Time: Support for People with Cancer
Facing Forward - Life After Cancer Treatment
Chemotherapy and You

More books from Progressive Management

Cover of the book Spain, The European Union and the United States in the Age of Terror: Spanish Strategic Culture and the Global War on Terror - Report on NATO Operations, Military Elites, History and Franco by Progressive Management
Cover of the book Apollo and America's Moon Landing Program: Apollo 13 Accident Cortright Review Board Report with Findings and Recommendations about the In-flight Oxygen Tank Explosion - Lovell, Haise, and Swigert by Progressive Management
Cover of the book Low-Intensity Conflict in the Third World: Middle East, Soviets, Russia, Latin America, South Africa, Southeast Asia, United States Policy and Strategic Planning by Progressive Management
Cover of the book After Desert Storm: The U.S. Army and the Reconstruction of Kuwait - Persian Gulf War Humanitarian Relief, Post-Hostilities, CENTCOM Civil-Military Operations, Task Force Freedom, Fighting Oil Fires by Progressive Management
Cover of the book Military Testing Facilities and Equipment - Army Natick Soldier RD and E Center (NSRDEC): Human Systems, Clothing, Engineering, Polymer, Mechanical Testing and Analysis, Applied Science, Food by Progressive Management
Cover of the book 21st Century U.S. Military Manuals: Opposing Force OPFOR Worldwide Equipment Guide (WEG) Part 5 - Ground Systems - Antitank and Anti-armor including Russian, Chinese, U.S., North Korean by Progressive Management
Cover of the book Between Heroes and Guardians: General Lyman L. Lemnitzer and General Charles H. Bonesteel III - World War II and Cold War, Operation Torch, Project Solarium, Interwar Period and Wartime Careers by Progressive Management
Cover of the book Small Unit Training in Subterranean Environments (TC 3-21.50) - Preparing to Fight in Underground Facilities, Bunkers, Subways, Sewers, Caves, Tunnels, WMD Bases with Applicability to North Korea by Progressive Management
Cover of the book National Defense Intelligence College Paper: Imperialism With Chinese Characteristics? Reading and Re-Reading China's 2006 Defense White Paper - Chinese Military Expansion, Maoist Policy by Progressive Management
Cover of the book Pushing the Horizon: Seventy-Five Years of High Stakes Science and Technology at the Naval Research Laboratory (NRL) - Thomas Edison, V-2, Vanguard, Operation Crossroads, Cold War Nuclear Secrets by Progressive Management
Cover of the book The Air Expeditionary Force (AEF) in Perspective: World War II, Norway, Guadalcanal, Rommel, Soviets in Spain, World War I, Gallipoli, Egyptian Force, Iraq Kut Disaster, Napoleon, Boxer Rebellion by Progressive Management
Cover of the book 21st Century U.S. Military Documents: Antiterrorism (Air Force Instruction 10-245 21) - AT Program, Standards, Force Protection, Terrorist Threat Levels, Suspicious Activity by Progressive Management
Cover of the book Essential Guide to America's National Parks: Official Index for 2016, Complete Listing of All NPS Areas by State, with National Parks, Wilderness and Heritage Areas, Wild and Scenic Rivers, Trails by Progressive Management
Cover of the book Geothermal Technologies Market Report: Department of Energy Report on the Status of Geothermal Power, Investment, American Activity, Leasing and Permitting, Employment and Economic Benefits by Progressive Management
Cover of the book FEMA Document Series: Federal Guidelines for Dam Safety: Emergency Action Planning for Dam Owners by Progressive Management
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy